First Time Loading...

Biocept Inc
NASDAQ:BIOC

Watchlist Manager
Biocept Inc Logo
Biocept Inc
NASDAQ:BIOC
Watchlist
Price: 0.0698 USD 125.16% Market Closed
Updated: May 2, 2024

Biocept Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biocept Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Biocept Inc
NASDAQ:BIOC
Net Income (Common)
-$32.1m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$4.8B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$484m
CAGR 3-Years
17%
CAGR 5-Years
-39%
CAGR 10-Years
-20%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Biocept Inc's Net Income (Common)?
Net Income (Common)
-32.1m USD

Based on the financial report for Dec 31, 2022, Biocept Inc's Net Income (Common) amounts to -32.1m USD.

What is Biocept Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-8%

Over the last year, the Net Income (Common) growth was -1 036%. The average annual Net Income (Common) growth rates for Biocept Inc have been -8% over the past three years , -8% over the past five years .